Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study

NCT00927420 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00927420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2009
Completion date
October 31, 2009
Enrollment
300 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.